Reply

This publication has 13 references indexed in Scilit:

• The Peritoneal Cavity Provides a Protective Niche for B1 and Conventional B Lymphocytes during Anti-CD20 Immunotherapy in Mice
  The Journal of Immunology, 2005
• Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy
  The Journal of Immunology, 2005
• CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms
  Nature Immunology, 2004
• The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
  The Journal of Experimental Medicine, 2004
• Severely Impaired B Lymphocyte Proliferation, Survival, and Induction of the c-Myc:Cullin 1 Ubiquitin Ligase Pathway Resulting from CD22 Deficiency on the C57BL/6 Genetic Background
  The Journal of Immunology, 2004
• CD22-directed monoclonal antibody therapy for lymphoma
  Seminars in Oncology, 2003
• Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of90Y-DOTA-peptide-Lym-1 in lymphoma xenografts
  Blood, 2003
• CD22 regulates thymus-independent responses and the lifespan of B cells
  Nature, 1996
• Involvement of p72syk kinase, p53/561yn kinase and phosphatidyl inositol‐3 kinase in signal transduction via the human B lymphocyte antigen CD22
  European Journal of Immunology, 1996
• Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2
  Cancer Immunology, Immunotherapy, 1993